Latest filings (excl ownership)
6-K
Report of Foreign Private Issuer
25 Sep 24
6-K
Report of Foreign Private Issuer
20 Aug 24
6-K
Collplant Biotechnologies Reports 2024 Second Quarter Financial Results and Provides Corporate Update
20 Aug 24
6-K
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
19 Aug 24
6-K
CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report
29 Jul 24
6-K
CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data
6 Jun 24
S-8
Registration of securities for employees
29 May 24
6-K
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
29 May 24
6-K
Collplant Biotechnologies Reports 2023 Full Year Financial Results and Provides Corporate Update
4 Apr 24
20-F
2023 FY
Annual report (foreign)
4 Apr 24
6-K
CollPlant Issues Letter to Shareholders
15 Feb 24
6-K
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
2 Jan 24
6-K
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
29 Nov 23
6-K
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
1 Nov 23
6-K
Current report (foreign)
10 Oct 23
6-K
CollPlant Biotechnologies Joins the United Nations Global Compact, The World’s Largest Corporate Sustainability Initiative
21 Sep 23
6-K
Report of Foreign Private Issuer
1 Sep 23
6-K
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
24 Aug 23
6-K
Report of Foreign Private Issuer
18 Jul 23
6-K
CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement
26 Jun 23
6-K
Report of Foreign Private Issuer
8 Jun 23
6-K
CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update
24 May 23
S-8
Registration of securities for employees
18 Apr 23
6-K
Report of Foreign Private Issuer
11 Apr 23
6-K
Report of Foreign Private Issuer
4 Apr 23
6-K
Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update
29 Mar 23
20-F
2022 FY
Annual report (foreign)
29 Mar 23
6-K
CollPlant Issues Letter to Shareholders
24 Jan 23
EFFECT
Notice of effectiveness
13 Jan 23
CORRESP
Correspondence with SEC
9 Jan 23
UPLOAD
Letter from SEC
6 Jan 23
6-K
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast
4 Jan 23
6-K
CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form
3 Jan 23
F-3
Shelf registration (foreign)
30 Dec 22
6-K
CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
1 Dec 22
6-K
Report of Foreign Private Issuer
17 Nov 22
6-K
CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based
15 Nov 22
6-K
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D 90
7 Nov 22
6-K
Report of Foreign Private Issuer
26 Aug 22
6-K
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
25 Aug 22
Latest ownership filings
SC 13G/A
Roumell Asset Management, LLC
13 Feb 24
SC 13G/A
Loewenbaum Lilian S.
25 Jan 24
144
Notice of proposed sale of securities
22 Sep 23
144
Notice of proposed sale of securities
12 Sep 23
SC 13G/A
MEITAV INVESTMENT HOUSE LTD
24 Jul 23
144
Notice of proposed sale of securities
14 Jun 23
SC 13G
Roumell Asset Management, LLC
13 Feb 23
SC 13G/A
INVESTMENT MANAGEMENT OF VIRGINIA LLC
30 Jan 23
SC 13G/A
Loewenbaum Lilian S.
25 Jan 23
SC 13G/A
MEITAV DASH INVESTMENTS LTD
11 Jan 23
SC 13G/A
Hargrove Reginald J.
24 Feb 22
SC 13G/A
Loewenbaum Lilian S.
23 Feb 22
SC 13G/A
MEITAV DASH INVESTMENTS LTD
2 Feb 22
SC 13G
INVESTMENT MANAGEMENT OF VIRGINIA LLC
31 Jan 22
SC 13G/A
JKALL Holdings, LLC
17 Feb 21
SC 13G/A
Loewenbaum Lilian S.
17 Feb 21
SC 13G/A
MEITAV DASH INVESTMENTS LTD
2 Feb 21
SC 13G/A
Loewenbaum Lilian S.
27 Nov 20
SC 13G/A
Hargrove Reginald J.
27 Nov 20
SC 13G/A
CollPlant Biotechnologies Ltd
12 Feb 20
SC 13D/A
CollPlant Biotechnologies Ltd
5 Nov 19
SC 13G
CollPlant Biotechnologies Ltd
18 Sep 19
SC 13G
CollPlant Biotechnologies Ltd
18 Sep 19
SC 13G
CollPlant Biotechnologies Ltd
16 Sep 19
SC 13D/A
CollPlant Biotechnologies Ltd
12 Aug 19
SC 13D/A
CollPlant Biotechnologies Ltd
20 Jun 19
SC 13D
CollPlant Holdings Ltd.
11 Feb 19
SC 13G/A
CollPlant Holdings Ltd.
7 Feb 19
SC 13G
CollPlant Holdings Ltd.
18 May 18